Skip to content

Effect of Remimazolam on Postoperative Cough in Patients Undergoing Thyroid Surgery: A Randomized Controlled Clinical Trial

Effect of Remimazolam on Postoperative Cough in Patients Undergoing Thyroid Surgery: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105311
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cough during emergence from anesthesia

Interventions

Remimazolam group:Maintenance with intravenous infusion of remimazolam
normal saline group:Maintenance with intravenous infusion of normal saline

Sponsors

Nanchong City Central Hospital, Second Clinical Medical College, North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing thyroid surgery under general anesthesia with endotracheal intubation. 2.Aged between 18 and 65 years. 3.American Society of Anesthesiologists (ASA) physical status classification I to III. 4.Body mass index (BMI) between 18.5 and 30 kg/m^2.

Exclusion criteria

Exclusion criteria: 1.Acute heart failure, unstable angina, myocardial infarction within the past 6 months, or resting heart rate = 160 mmHg or diastolic blood pressure >= 100 mmHg; 3. Acute respiratory tract infection, acute exacerbation of chronic obstructive pulmonary disease (COPD), or poorly controlled asthma; 4. End-stage renal failure or decompensated hepatic function; 5. Psychiatric disorders including schizophrenia, mania, bipolar disorder, or cognitive impairment; 6. Allergy to benzodiazepines; 7. History of benzodiazepine use within the past 3 months or previous general anesthesia; 8. Severe surgical complications such as thyroid storm, recurrent laryngeal nerve injury, or airway collapse; 9. Pregnant or lactating women; 10. Individuals with psychosocial issues or other reasons making them unable to cooperate.

Design outcomes

Primary

MeasureTime frame
Incidence of cough;

Secondary

MeasureTime frame
Severity of cough;Adverse reaction;

Countries

China

Contacts

Public ContactLinji Li

Nanchong City Central Hospital, Second Clinical Medical College, North Sichuan Medical College

llj-stephen@163.com+86 155 8300 9555

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026